Sildenafil Citrate  Tablets for PAH

20 mg



Sildenafil is indicated for treating pulmonary arterial hypertension (PAH). Unipharm’s generic Sildenafil Citrate Tablets for PAH have been manufactured and marketed in Israel since 2013.

  • ATC4: G04BE
  • Strengths: 20 mg
  • Dosage form: Tablets
  • Out-licensing is offered for all international markets*
  • Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products